Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Examining factors associated with experiencing cardiac arrhythmias in Black and White breast cancer survivors who received anthracyclines or trastuzumab

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07671-0Source: DataRank Database

Examining factors associated with experiencing cardiac arrhythmias in Black and White breast cancer survivors who received anthracyclines or trastuzumab is a research paper published in Breast Cancer Research and Treatment (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.44)OA: hybridTopics (62)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jinlei Zhao ORCID,Jian He ORCID,Katherine Y. Tossas ORCID,Wendy Bottinor ORCID,Vanessa B. Sheppard ORCID

Live enrichment

PubMed:40146434 PMC:PMC12006251 OpenAlex:https://openalex.org/W4408922029

NIH-NCI Cancer Center Support

Grant: P30CA016059

National Institutes of Health/National Cancer Institute

Grant: K99CA250638

National Institutes of Health

Grant: 4P30CA016059-35

Massey Cancer Center Support Grant

FWCI

1.44

Citation Percentile

0.8%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1007/s10549-025-07671-0

HYBRIDhttps://doi.org/10.1007/s10549-025-07671-0

publisherhttps://doi.org/10.1007/s10549-025-07671-0

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-025-07671-0.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-025-07671-0/fulltext.html

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationCancer Treatment and PharmacologyCardiac electrophysiology and arrhythmiasMedicine03 medical and health sciences0302 clinical medicineAdultAgedFemaleHumansMiddle AgedAnthracyclinesArrhythmias, CardiacBlack or African AmericanBreast NeoplasmsCancer SurvivorsRetrospective StudiesRisk FactorsTrastuzumabWhite

MeSH Terms

TrastuzumabCancer SurvivorsWhiteAdultAgedArrhythmias, CardiacBlack or African AmericanBreast NeoplasmsFemaleHumansMiddle AgedRetrospective StudiesRisk FactorsAnthracyclinesWhite People

Keywords

TrastuzumabMedicineBreast cancerOncologyInternal medicineWhite (mutation)CardiotoxicityCardiac toxicityChemotherapyCancerHypertensionCardiac ArrhythmiasRacial DisparitiesAdultResearchArrhythmias, CardiacBreast NeoplasmsWhiteMiddle AgedBlack or African AmericanCancer SurvivorsRisk FactorsHumansFemaleAnthracyclinesAgedRetrospective Studies